HIF1 was reported to regulate the expression of AGPAT2 (encoding an enzyme involved in the triacylglycerol biosynthetic pathway) in HCC and cervical adenocarcinoma cells. This evidence concerns the gene AGPAT2 and cervical adenocarcinoma.